INTRODUCTION {#h0.0}
============

*Staphylococcus aureus* is a Gram-positive opportunistic pathogen that is a significant cause of both health care- and community-associated infectious disease and is responsible for nearly 500,000 hospitalizations per year in the United States ([@B1]). This versatile organism uses a wide array of virulence factors to cause many types of infections, including cutaneous lesions, pneumonia, osteomyelitis, and toxic shock syndrome ([@B2]). Although many virulence factors have been characterized, *S. aureus* produces other putative virulence factors that are poorly studied. One example is the *spl* (serine protease-like) operon, which is found on the νSaβ pathogenicity island and carries six serine protease genes (*splA*, *splB*, *splC*, *splD*, *splE*, and *splF*) ([@B3], [@B4]). The *spl* operon is not found in the other staphylococci but is present in most strains of *S. aureus*, although some strains do not have the full operon ([@B3], [@B5]). The SplD and SplF amino acid sequences are 94.6% identical ([@B3]). The natural substrates and virulence roles of the Spl proteases are unknown; however, there is evidence that they are involved in colonization or infection of the host.

The *spl* locus was first identified in a study of anti-*S. aureus* antibodies generated in patients with invasive *S. aureus* infections. In a screen of *S. aureus* proteins, one that had strong reactivity with the patients' antisera was characterized. Sequence analysis of the open reading frame (ORF) identified revealed that it was a putative serine protease and appeared to be within an operon ([@B6]). The ORF identified was later found to be SplC ([@B3]). Since then, the Spls have been demonstrated to be immunogenic in individuals with *S. aureus* infections, as well as healthy individuals colonized by *S. aureus* ([@B5], [@B7]). A recent study also identified the Spls as immunogenic in the airway, particularly in patients with severe asthma ([@B8]). Strikingly, the same study also discovered peptide fragments of SplD and SplF in human nasal polyp tissue. Therefore, it is well established that Spl proteases are secreted *in vivo* and are potentially involved in *S. aureus*-host interaction.

The goal of this study was to investigate the role of the Spl proteases in infection and identify possible Spl cleavage targets. Using a community-associated methicillin-resistant *S. aureus* (CA-MRSA) USA300 strain, we found that an *spl* deletion mutant was not attenuated in lethality in a rabbit pneumonia model but was able to induce severe damage in only one lung. In contrast, the USA300 wild-type (WT) strain induced more diffuse disease, affecting both lungs equally. We also demonstrated that SplA is able to cleave mucin 16 from the human lung cell line CalU-3, which is the first identification of a host protein as a substrate for an Spl protease. Proteomic studies show that the *spl* mutant has an altered abundance of many proteins both on the cell surface and secreted, suggesting that Spls may target *S. aureus* proteins as well.

RESULTS {#h1}
=======

*spl* mutant produces localized pneumonia in rabbit model of infection. {#s1.1}
-----------------------------------------------------------------------

To study the function of the Spls during host infection, we compared the USA300 WT strain LAC and an allelic replacement *spl* operon mutant (Δ*spl*::*erm*) in a rabbit pneumonia model of infection. LAC is a CA-MRSA USA300 strain (here USA300 WT), and this USA300 lineage has become the most frequent cause of CA-MRSA infections in North America and is increasingly reported both overseas and in hospital-associated MRSA (HA-MRSA) infections ([@B9], [@B10]). USA300 strains have been isolated from both CA-MRSA and HA-MRSA pneumonia patients ([@B11], [@B12]). Animal models have demonstrated that the *S. aureus sae* regulatory system and various *sae-*regulated factors are important in *S. aureus* pneumonia ([@B13][@B14][@B17]). Since the Spls are directly regulated by *sae* ([@B13]), we predicted that pneumonia would be a relevant model to investigate their role in virulence.

The rabbit pneumonia model was performed as previously described ([@B18]). Rabbits were infected with either USA300 WT or Δ*spl*::*erm* mutant bacteria at a dose of 2 × 10^9^ CFU delivered directly to the lung through a catheter that was inserted at the trachea. After 6 days of infection, surviving rabbits were sacrificed. In a total of two experiments (*n =* 6 rabbits per group), 83% of the USA300 WT-infected rabbits (5 of 6) survived to day 6, while 33.3% of the *spl* mutant-infected rabbits (2 of 6) survived to day 6 (*P* = 0.11, [Fig. 1A](#fig1){ref-type="fig"}). Gross pathology and histopathology revealed significant lung damage in both groups. Gross pathology of a USA300 WT-infected rabbit that was euthanized on day 6 showed hemorrhage in both the left and right lungs ([Fig. 1B](#fig1){ref-type="fig"}, upper left). In a Δ*spl*::*erm* mutant-infected animal that also was euthanized on day 6, the left lung also showed a large area of hemorrhage, while the right lung appeared more intact, suggesting a more constrained distribution of lesions ([Fig. 1B](#fig1){ref-type="fig"}, upper right). Histopathology also revealed edema, inflammatory infiltrates, and pleuritis in infected lungs from both groups of animals. Hematoxylin and eosin (H&E) straining of the left lungs of USA300 WT-infected ([Fig. 1B](#fig1){ref-type="fig"}, lower left) and Δ*spl*::*erm* mutant-infected ([Fig. 1B](#fig1){ref-type="fig"}, lower right) rabbits euthanized on day 6 demonstrated these findings in both animals.

![USA300 *spl* mutant causes unilateral pneumonia. (A) Survival of rabbits infected with the USA300 WT or *spl* mutant strain (*n* = 6). Two experiments were performed, with three rabbits per group in each experiment. The *P* value (0.11) was calculated with a log rank (Mantel-Cox) test. (B) Gross pathology (top) and histopathology (bottom) of USA300 WT and *spl* mutant strain-infected rabbit lungs euthanized on day 6. Histopathology of H&E-stained infected lung tissue is shown. (C) Total histopathology score of each lung, combined from six scoring categories. *n =* 12 lungs per group. (D) Bronchopneumonia score of each lung. *n =* 12 lungs per group. *P* = 0.09 calculated with an unpaired, two-tailed *t* test. (E) Difference between the left and right lung scores of each rabbit. For each rabbit, the value of the lung with the lower total clinical score was subtracted from the value of the lung with the higher clinical score. *n =* 6 rabbits per group. The *P* value was calculated with an unpaired, two-tailed *t* test.](sph0051621630001){#fig1}

Histopathology scoring of the lungs of all of the infected rabbits in both groups was also performed, regardless of the time of death. The lungs were scored on the presence of pleuritis, edema, bronchopneumonia, necrosis, lymphoid cell/heterophil infiltration, and Gram-positive bacteria. Each of the six categories was given a score of 0 (within normal limits) to 3 (severe and extensive). The average total histopathology scores were nearly identical in WT strain-infected rabbits and Δ*spl*::*erm* mutant-infected rabbits ([Fig. 1C](#fig1){ref-type="fig"}), and rabbits in both groups exhibited bronchopneumonia ([Fig. 1D](#fig1){ref-type="fig"}). Interestingly, the Δ*spl*::*erm* mutant-infected rabbits displayed a pattern of one high-scoring lung and one low-scoring lung, while lung scores appeared more evenly distributed in the WT strain-infected rabbits ([Fig. 1C](#fig1){ref-type="fig"} and [E](#fig1){ref-type="fig"}). A D'Agostino-Pearson normality test determined that the WT strain-infected lung scores follow a normal distribution (*P* = 0.27), while mutant-infected lung scores do not (*P* = 0.01), suggesting that the mutant-infected lungs represent two distinct populations. When the difference in score between the two lungs was calculated (Δ lung score) for each rabbit, the *spl* mutant-infected rabbits had a significantly greater difference between their lungs than WT strain-infected rabbits did ([Fig. 1E](#fig1){ref-type="fig"}, *P* = 0.012). On the whole, these findings indicate that although no significant difference in the lethality of the Δ*spl*::*erm* mutant was observed, this mutant also produced a clear phenotype of lung damage that has a constrained localization within the lungs.

SplA induces mucin 16 release from CalU-3 cells. {#s1.2}
------------------------------------------------

Mucin 16 is an \~25-MDa, heavily glycosylated cell surface protein that is found on multiple epithelial tissues in the body, including the ocular surface and airway epithelia ([@B19][@B20][@B21]). Like other mucins, mucin 16 provides lubrication of epithelia, as well as a protective barrier against pathogens. Two studies have reported that RNA interference-mediated knockdown of mucin 16 in human corneal-limbal epithelial cells renders these cells more susceptible to *S. aureus* adherence ([@B22], [@B23]). Additionally, the *Streptococcus pneumoniae* metalloprotease ZmpC has been shown to cleave mucin 16 from a variety of human epithelial cell types, allowing the bacteria to increasingly invade these cells *in vitro* ([@B24]). An adenovirus capable of causing keratoconjunctivitis also was recently shown to induce mucin 16 release from ocular epithelial cells, facilitating infection ([@B25]). These findings demonstrate that *S. aureus* and other pathogens encounter mucin 16 as a barrier to the host epithelium and are able to disrupt this barrier in order to colonize or infect the host.

A study describing the crystal structure and cleavage site preference of SplA found that this enzyme has highly specific substrate requirements. In an experiment with a cellular library of peptide substrates, SplA was found to cleave exclusively substrates containing the Trp/Tyr-Leu-Tyr-Thr/Ser (W/Y-L-Y-T/S) motif ([@B26]). That study also noted that mucin 16 contains a Y-L-Y-S sequence and could be a likely target for SplA cleavage ([Fig. 2A](#fig2){ref-type="fig"}) ([@B26]). On the basis of this evidence, as well as our observation that the Δ*spl*::*erm* mutant exhibited more localized disease in the rabbit pneumonia model, we hypothesized that SplA cleaves mucin 16 from lung cells. To test this, confluent monolayers of the lung epithelial cell line CalU-3 were treated with purified, His6-tagged SplA. Because of the large size of mucin 16 ([Fig. 2A](#fig2){ref-type="fig"}), CalU-3 medium was tested for mucin 16 with a slot blot apparatus rather than by gel electrophoresis. Probing with a mucin 16 antibody revealed that mucin 16 is endogenously released from CalU-3 cells ([Fig. 2B](#fig2){ref-type="fig"}). This is in accordance with previous reports that mucin 16 is naturally shed from epithelia ([@B19], [@B27], [@B28]). Incubation with SplA increased this shedding in a dose-dependent manner. When SplA was treated with the serine protease inhibitor 3,4-dichloroisocoumarin (3,4-DCI) before it was added to the cells, mucin 16 shedding was decreased to a level similar to that in untreated cells ([Fig. 2B](#fig2){ref-type="fig"}). This suggests that SplA activity is required for mucin 16 removal, by either cleaving it at the Y-L-Y-S site or inducing its shedding indirectly by degradation of another substrate. This activity may allow *S. aureus* to perturb the airway epithelial barrier and cause more disseminated disease.

![SplA cleaves human mucin 16. (A) Diagram of human mucin 16. Mucin 16 is exposed on the cell surface and contains one putative SplA cleavage site. The N-terminal portion is heavily glycosylated, and the tandem repeat region contains several SEA (sea urchin sperm protein, enterokinase, and agrin) domains, which are present in various mucins. (B) Anti-mucin 16 slot blot assay of CalU-3 medium following treatment with SplA. One representative blot is shown.](sph0051621630002){#fig2}

The Δ*spl*::*erm* mutant retains viability in whole blood, hemolysis activity, and protease production. {#s1.3}
-------------------------------------------------------------------------------------------------------

*S. aureus* produces a multitude of virulence factors that function by thwarting the innate immune defenses of the infected host ([@B29]). Based on the *in vivo* phenotype of the Δ*spl*::*erm* mutant, we hypothesized that it may have an altered capacity to survive these immune assaults. To test this, we compared the survival of USA300 WT and Δ*spl*::*erm* mutant cells in whole human blood. Whole human blood contains cellular and complement-mediated innate immunity components and thus is used as a general assay of bacterial survival under these conditions. When log-phase bacteria were inoculated into whole human blood and incubated for 3 h, 60% of USA300 WT bacteria remained viable. However, 40% of Δ*spl*::*erm* mutant bacteria remained viable ([Fig. 3A](#fig3){ref-type="fig"}), although this difference was not statistically significant.

![Virulence factor production is unchanged in a USA300 *spl* mutant. (A) Survival of the USA300 WT and Δ*spl*::*erm* mutant strains in whole human blood. Bacteria were incubated with whole blood for 3 h. (B) Hemolysis activities of the USA300 WT and Δ*spl*::*erm* mutant strains. A dilution series of spent medium was incubated with rabbit erythrocytes. The graph shows the percentage of medium needed to lyse 50% of the erythrocytes (EC~50~). (C) ScpA activity of the USA300 WT and Δ*spl*::*erm* mutant strains measured over the course of culture growth. At each time point, spent medium was incubated with a FRET substrate for ScpA activity. Activity is shown as the rate at which fluorescence was generated by FRET substrate cleavage. (D) Milk plate proteolysis activities of the USA300 WT and Δ*spl*::*erm* mutant strains*.* Overnight cultures were spotted onto an agar plate containing 5% milk, and the halo around the colony corresponds to clearing of the milk.](sph0051621630003){#fig3}

Alternatively, we hypothesized that the Δ*spl*::*erm* mutant had altered production of one or more secreted virulence factors whose levels could be modulated by proteolytic degradation by the Spl proteases in *S. aureus*. To investigate this, the activity of the secreted alpha toxin (Hla) and the secreted proteases staphopain A (ScpA) and aureolysin (Aur) were compared in USA300 WT and Δ*spl*::*erm* mutant bacteria. Hla is a potent cytolysin and immunomodulatory virulence factor that has been shown to contribute to pathogenesis in a number of *S. aureus* infection models, including a murine model of pneumonia ([@B30], [@B31]). In an Hla activity assay ([@B32]), the Δ*spl*::*erm* mutant did not exhibit a change in Hla activity from the USA300 WT strain ([Fig. 3B](#fig3){ref-type="fig"}), indicating that hemolysis is unaffected by the Spls.

Next, we tested the activity levels of the *S. aureus* secreted proteases staphopain A (ScpA) and aureolysin (Aur). Both of these proteases inhibit the classical and alternative pathways of complement activation ([@B33]). ScpA also cleaves the neutrophil chemotaxis receptor CXCR2, blocking neutrophil recruitment ([@B34]), and exhibits activity against the extracellular matrix protein collagen, whose degradation could promote host damage during infection ([@B35]). Aur is able to inhibit complement activation by cleaving the complement protein C3 ([@B36]). ScpA activity in cell-free spent medium was tested with a FRET substrate containing the ScpA cleavage site from human CXCR2 ([@B34], [@B37]). Over the course of growth, the Δ*spl*::*erm* mutant displayed the same ScpA activity as the USA300 WT strain, indicating that the Spls do not affect ScpA activity ([Fig. 3C](#fig3){ref-type="fig"}). A milk plate assay to detect Aur activity showed no decrease in the Δ*spl*::*erm* mutant ([Fig. 3D](#fig3){ref-type="fig"}). On the whole, these results suggest that the Spls do not modulate ScpA or Aur activity.

Proteomic studies reveal differences between USA300 WT and Δ*spl*::*erm* mutant strain secreted and surface proteins. {#s1.4}
---------------------------------------------------------------------------------------------------------------------

Finally, the surface and secreted proteomes of the USA300 WT and Δ*spl*::*erm* mutant strains were analyzed. The objective of these experiments was to identify changes in protein levels that might explain the altered virulence phenotype of the Δ*spl*::*erm* mutant and suggest potential *S. aureus* proteins that are degraded by the Spls. The proteomic data were analyzed with the Scaffold program using Fisher's exact test, and all hits with a *P* value of ≤0.010 were considered significant. The surface proteomics identified 63 proteins that were detected with increasing abundance in the Δ*spl*::*erm* mutant relative to USA300 WT ([Table 1](#tab1){ref-type="table"}) and 21 proteins detected with decreasing abundance in the Δ*spl*::*erm* mutant ([Table 2](#tab2){ref-type="table"}). A few genes involved in virulence and immune evasion were increased in the Δ*spl*::*erm* mutant, including those encoding IsdA and SpA. IsdA promotes *S. aureus* adherence to desquamated nasal epithelial cells ([@B38]), fibrinogen, and fibronectin ([@B39]) and enhances *S. aureus* survival of bactericidal fatty acids and peptides in human skin ([@B40]). SpA binds to IgG, which protects *S. aureus* from opsonophagocytosis and dysregulates the host adaptive immune response ([@B41], [@B42]). The cell wall-associated protein EbpS was also increased on the surface of *spl* mutant bacteria. Although EbpS was once thought to act as an adhesin by binding to elastin, recent studies have found that its contribution to bacterial adhesion is minimal ([@B43]). However, EbpS does mediate Zn^2+^-dependent growth and biofilm formation ([@B44]). Further, an investigation of the differential expression of *S. aureus* genes in murine models of colonization and pathogenesis found that *ebpS* was significantly upregulated in the blood relative to the nares ([@B45]). Therefore, this protein may play a role during infection. Increased levels of these proteins could enhance *S. aureus* immunomodulation and virulence.

###### 

Proteins increased on *spl* mutant surface

  GenBank (UniProt) accession no.                                                                                      Name                                                                                                     Biological function(s)                                                                   Avg no. of assigned spectra   *P* value[^a^](#ngtab1.1){ref-type="table-fn"}   
  -------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------- ----------------------------- ------------------------------------------------ -------------
  [Q2FGW1](https://www.ncbi.nlm.nih.gov/protein/Q2FGW1) ([EBPS_STAA3](http://www.uniprot.org/uniprot/Q2FGW1))          Elastin-binding protein EbpS                                                                             Adhesion, biofilm formation                                                              24.00                         47.67                                            0.00000021
  [Q2FHV1](https://www.ncbi.nlm.nih.gov/protein/Q2FHV1) ([ISDA_STAA3](http://www.uniprot.org/uniprot/Q2FHV1))          Iron-regulated surface determinant protein A IsdA                                                        Adhesion, immune evasion                                                                 113.33                        136.00                                           0.0018
  [Q2FDT8](https://www.ncbi.nlm.nih.gov/protein/Q2FDT8) ([ISAA_STAA3](http://www.uniprot.org/uniprot/Q2FDT8))          Transglycosylase IsaA                                                                                    Autolysis                                                                                37.67                         60.33                                            0.000013
  [Q2FGW9](https://www.ncbi.nlm.nih.gov/protein/Q2FGW9) ([Q2FGW9_STAA3](http://www.uniprot.org/uniprot/Q2FGW9))        DNA-binding protein HU/Hup                                                                               Housekeeping, DNA structure                                                              40.67                         68.67                                            0.00000046
  [Q2FF94](https://www.ncbi.nlm.nih.gov/protein/Q2FF94) ([CH10_STAA3](http://www.uniprot.org/uniprot/Q2FF94))          10-kDa chaperonin GroS                                                                                   Housekeeping, protein folding                                                            5.67                          12.67                                            0.0022
  [Q2FDV8](https://www.ncbi.nlm.nih.gov/protein/Q2FDV8) ([CLPL_STAA3](http://www.uniprot.org/uniprot/Q2FDV8))          ATP-dependent protease ClpL                                                                              Housekeeping, protein turnover                                                           2.33                          13.00                                            0.00000054
  [Q2FGB6](https://www.ncbi.nlm.nih.gov/protein/Q2FGB6) ([GREA_STAA3](http://www.uniprot.org/uniprot/Q2FGB6))          Transcription elongation factor GreA                                                                     Housekeeping, transcription                                                              115.33                        153.67                                           0.0000033
  [Q2FJA3](https://www.ncbi.nlm.nih.gov/protein/Q2FJA3) ([RL11_STAA3](http://www.uniprot.org/uniprot/Q2FJA3))          50S ribosomal protein R11 RplK                                                                           Housekeeping, translation                                                                250.00                        320.67                                           2.4E−09
  [Q2FFJ4](https://www.ncbi.nlm.nih.gov/protein/Q2FFJ4) ([GATC_STAA3](http://www.uniprot.org/uniprot/Q2FFJ4))          Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit C GATC                                          Housekeeping, translation                                                                41.67                         57.00                                            0.0019
  [Q2FER1](https://www.ncbi.nlm.nih.gov/protein/Q2FER1) ([IF1_STAA3](http://www.uniprot.org/uniprot/Q2FER1))           Translation initiation factor IF-1 InfA                                                                  Housekeeping, translation                                                                15.33                         26.33                                            0.0011
  [Q2FEQ4](https://www.ncbi.nlm.nih.gov/protein/Q2FEQ4) ([RL6_STAA3](http://www.uniprot.org/uniprot/Q2FEQ4))           50S ribosomal protein L6 RplF                                                                            Housekeeping, translation                                                                8.33                          14.67                                            0.01
  [Q2FFJ6](https://www.ncbi.nlm.nih.gov/protein/Q2FFJ6) ([GATB_STAA3](http://www.uniprot.org/uniprot/Q2FFJ6))          Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B GatB                                          Housekeeping, translation                                                                0.00                          6.00                                             0.0002
  [Q2FF08](https://www.ncbi.nlm.nih.gov/protein/Q2FF08) ([RL31B_STAA3](http://www.uniprot.org/uniprot/Q2FF08))         50S ribosomal protein L31 type B RpmE2                                                                   Housekeeping, translation                                                                2.67                          7.00                                             0.0096
  [Q2FEQ7](https://www.ncbi.nlm.nih.gov/protein/Q2FEQ7) ([RL30_STAA3](http://www.uniprot.org/uniprot/Q2FEQ7))          50S ribosomal protein L30 RpmD                                                                           Housekeeping, translation                                                                0.00                          2.33                                             0.007
  [Q2FJU4](https://www.ncbi.nlm.nih.gov/protein/Q2FJU4) ([Q2FJU4_STAA3](http://www.uniprot.org/uniprot/Q2FJU4))        Triacylglycerol lipase GehB/SAL2                                                                         Lipase                                                                                   8.67                          32.33                                            1.2E−11
  [Q2FH26](https://www.ncbi.nlm.nih.gov/protein/Q2FH26) ([ODO2_STAA3](http://www.uniprot.org/uniprot/Q2FH26))          Dihydrolipoyllysine residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex OdhB   Metabolism, amino acid degradation                                                       0.00                          2.33                                             0.007
  [Q2FHD0](https://www.ncbi.nlm.nih.gov/protein/Q2FHD0) ([Q2FHD0_STAA3](http://www.uniprot.org/uniprot/Q2FHD0))        Glutamine synthetase GlnA                                                                                Metabolism, amino acid metabolism, glutamine synthesis                                   26.33                         47.33                                            0.0000045
  [Q2FDV3](https://www.ncbi.nlm.nih.gov/protein/Q2FDV3) ([Roca_STAA3](http://www.uniprot.org/uniprot/Q2FDV3))          1-Pyrroline-5-carboxylate dehydrogenase RocA                                                             Metabolism, amino acid metabolism, proline catabolism                                    0.00                          31.67                                            5E−30
  [Q2FJC8](https://www.ncbi.nlm.nih.gov/protein/Q2FJC8) ([Q2FJC8_STAA3](http://www.uniprot.org/uniprot/Q2FJC8))        Cysteine synthase CysK                                                                                   Metabolism, amino acid synthesis                                                         82.33                         133.00                                           7.4E−11
  [Q2FH38](https://www.ncbi.nlm.nih.gov/protein/Q2FH38) ([Q2FH38_STAA3](http://www.uniprot.org/uniprot/Q2FH38))        Diaminopimelate decarboxylase LysA                                                                       Metabolism, amino acid synthesis                                                         0.00                          2.33                                             0.007
  [Q2FF22](https://www.ncbi.nlm.nih.gov/protein/Q2FF22) ([ATPA_STAA3](http://www.uniprot.org/uniprot/Q2FF22))          ATP synthase subunit alpha AtpA                                                                          Metabolism, ATP synthesis (general metabolism)                                           22.67                         32.00                                            0.01
  [Q2FKD2](https://www.ncbi.nlm.nih.gov/protein/Q2FKD2) ([Q2FKD2_STAA3](http://www.uniprot.org/uniprot/Q2FKD2))        Acetoin (diacetyl) reductase SAUSA300_0129                                                               Metabolism, carbohydrate metabolism                                                      6.00                          12.33                                            0.0052
  [Q2FK29](https://www.ncbi.nlm.nih.gov/protein/Q2FK29) ([LDH1_STAA3](http://www.uniprot.org/uniprot/Q2FK29))          [l]{.smallcaps}-Lactate dehydrogenase 1 Ldh1                                                             Metabolism, carbohydrate metabolism                                                      0.00                          6.00                                             0.0000028
  [Q2FFV5](https://www.ncbi.nlm.nih.gov/protein/Q2FFV5) ([PCKA_STAA3](http://www.uniprot.org/uniprot/Q2FFV5))          Phosphoenolpyruvate carboxykinase PckA                                                                   Metabolism, carbohydrate metabolism, gluconeogenesis                                     12.67                         35.00                                            0.000000003
  [Q2FG39](https://www.ncbi.nlm.nih.gov/protein/Q2FG39) ([Q2FG39_STAA3](http://www.uniprot.org/uniprot/Q2FG39))        6-Phosphofructokinase PfkA                                                                               Metabolism, carbohydrate metabolism, glycolysis                                          18.00                         36.67                                            0.0000028
  [Q2FDQ4](https://www.ncbi.nlm.nih.gov/protein/Q2FDQ4) ([ALF1_STAA3](http://www.uniprot.org/uniprot/Q2FDQ4))          Fructose-bisphosphate aldolase class 1 Fda                                                               Metabolism, carbohydrate metabolism, glycolysis                                          0.00                          6.67                                             0.00000069
  [Q2FGM3](https://www.ncbi.nlm.nih.gov/protein/Q2FGM3) ([Q2FGM3_STAA3](http://www.uniprot.org/uniprot/Q2FGM3))        6-Phosphogluconate dehydrogenase, decarboxylating Gnd                                                    Metabolism, carbohydrate metabolism, pentose phosphate pathway                           139.00                        166.33                                           0.00072
  [Q2FFW0](https://www.ncbi.nlm.nih.gov/protein/Q2FFW0) ([Q2FFW0_STAA3](http://www.uniprot.org/uniprot/Q2FFW0))        Transaldolase SAUSA300_1725                                                                              Metabolism, carbohydrate metabolism, pentose phosphate pathway                           40.67                         66.33                                            0.0000026
  [Q2FEZ2](https://www.ncbi.nlm.nih.gov/protein/Q2FEZ2) ([Q2FEZ2_STAA3](http://www.uniprot.org/uniprot/Q2FEZ2)) (+1)   Deoxyribose-phosphate aldolase DeoC                                                                      Metabolism, carbohydrate metabolism, pentose phosphate pathway                           4.00                          10.67                                            0.0013
  [Q2FHZ7](https://www.ncbi.nlm.nih.gov/protein/Q2FHZ7) ([Q2FHZ7_STAA3](http://www.uniprot.org/uniprot/Q2FHZ7))        Phosphocarrier protein HPr/PtsH                                                                          Metabolism, carbohydrate metabolism, sugar PTS [^b^](#ngtab1.2){ref-type="table-fn"}     22.67                         50.67                                            1.7E−09
  [Q2FE56](https://www.ncbi.nlm.nih.gov/protein/Q2FE56) ([Q2FE56_STAA3](http://www.uniprot.org/uniprot/Q2FE56))        NAD-dependent epimerase/dehydratase family protein SAUSA300_2387                                         Metabolism, cofactors and vitamins                                                       7.67                          14.33                                            0.0065
  [Q2FJM5](https://www.ncbi.nlm.nih.gov/protein/Q2FJM5) ([GUAA_STAA3](http://www.uniprot.org/uniprot/Q2FJM5))          GMP synthase GuaA                                                                                        Metabolism, nucleotide metabolism                                                        0.00                          8.00                                             0.00000004
  [Q2FI07](https://www.ncbi.nlm.nih.gov/protein/Q2FI07) ([PUR5_STAA3](http://www.uniprot.org/uniprot/Q2FI07))          Phosphoribosylformylglycinamidine cyclo-ligase PurM                                                      Metabolism, nucleotidemetabolism                                                         0.00                          2.67                                             0.0034
  [Q2FI11](https://www.ncbi.nlm.nih.gov/protein/Q2FI11) ([Q2FI11_STAA3](http://www.uniprot.org/uniprot/Q2FI11))        Phosphoribosylformylglycinamidine synthase PurS                                                          Metabolism, nucleotide metabolism                                                        0.00                          2.67                                             0.0034
  [Q2FI15](https://www.ncbi.nlm.nih.gov/protein/Q2FI15) ([FOLD_STAA3](http://www.uniprot.org/uniprot/Q2FI15))          Bifunctional protein FolD                                                                                Metabolism, one-carbon metabolism, tetrahydrofolate interconversion                      317.33                        350.00                                           0.0017
  [Q2FFV8](https://www.ncbi.nlm.nih.gov/protein/Q2FFV8) ([Q2FFV8_STAA3](http://www.uniprot.org/uniprot/Q2FFV8))        Oxidoreductase SAUSA300_1728                                                                             Oxidoreductase                                                                           99.67                         123.33                                           0.00084
  [Q2FIB9](https://www.ncbi.nlm.nih.gov/protein/Q2FIB9) ([Q2FIB9_STAA3](http://www.uniprot.org/uniprot/Q2FIB9))        NADH-dependent flavin oxidoreductase SAUSA300_0859                                                       Oxidoreductase/FMN[^c^](#ngtab1.3){ref-type="table-fn"} binding                          0.00                          3.00                                             0.0017
  [Q2FEB6](https://www.ncbi.nlm.nih.gov/protein/Q2FEB6) ([Q2FEB6_STAA3](http://www.uniprot.org/uniprot/Q2FEB6))        Putative uncharacterized protein SAUSA300_2327                                                           Putative FMN binding and pyridoxamine-phosphate oxidase (general metabolism/oxidation)   30.67                         52.67                                            0.0000055
  [Q2FFZ4](https://www.ncbi.nlm.nih.gov/protein/Q2FFZ4) ([Q2FFZ4_STAA3](http://www.uniprot.org/uniprot/Q2FFZ4))        Putative thioredoxin SAUSA300_1690                                                                       Putative housekeeping, redox homeostasis                                                 246.67                        285.67                                           0.00016
  [Q2FEY0](https://www.ncbi.nlm.nih.gov/protein/Q2FEY0) ([Q2FEY0_STAA3](http://www.uniprot.org/uniprot/Q2FEY0))        Haloacid dehalogenase-like hydrolase SAUSA300_2102                                                       Putative hydrolase activity                                                              0.00                          2.67                                             0.0034
  [Q2FFH4](https://www.ncbi.nlm.nih.gov/protein/Q2FFH4) ([Y1902_STAA3](http://www.uniprot.org/uniprot/Q2FFH4))         Conserved hypothetical protein, putative lactonase SAUSA300_1902                                         Putative lactonase activity                                                              9.33                          22.33                                            0.00002
  [Q2FGJ2](https://www.ncbi.nlm.nih.gov/protein/Q2FGJ2) ([Q2FGJ2_STAA3](http://www.uniprot.org/uniprot/Q2FGJ2))        Proline dipeptidase SAUSA300_1491                                                                        Putative peptidase activity (aminopeptidase)                                             3.67                          10.00                                            0.0016
  [Q2FFL6](https://www.ncbi.nlm.nih.gov/protein/Q2FFL6) ([Q2FFL6_STAA3](http://www.uniprot.org/uniprot/Q2FFL6))        Aminopeptidase PepS                                                                                      Putative peptidase activity (aminopeptidase)                                             0.00                          4.00                                             0.0002
  [Q2FG30](https://www.ncbi.nlm.nih.gov/protein/Q2FG30) ([Y1654_STAA3](http://www.uniprot.org/uniprot/Q2FG30))         Uncharacterized peptidase SAUSA300_1654                                                                  Putative peptidase activity (dipeptidase)                                                1.00                          19.67                                            3.4E−15
  [Q2FFM0](https://www.ncbi.nlm.nih.gov/protein/Q2FFM0) ([Q2FFM0_STAA3](http://www.uniprot.org/uniprot/Q2FFM0))        Uncharacterized putative glycosyl hydrolase SAUSA300_1856                                                Putative peptidase activity (endopeptidase)                                              0.00                          16.00                                            1.6E−15
  [Q2FI96](https://www.ncbi.nlm.nih.gov/protein/Q2FI96) ([Q2FI96_STAA3](http://www.uniprot.org/uniprot/Q2FI96))        Conserved hypothetical protein SAUSA300_0882                                                             Putative phospholipid-binding protein                                                    0.00                          2.33                                             0.007
  [Q2FIJ2](https://www.ncbi.nlm.nih.gov/protein/Q2FIJ2) ([OHRL_STAA3](http://www.uniprot.org/uniprot/Q2FIJ2))          Organic hydroperoxide resistance protein-like protein SAUSA300_0786                                      Putative stress response, oxidative stress (putative)                                    0.00                          2.33                                             0.007
  [Q2FJY6](https://www.ncbi.nlm.nih.gov/protein/Q2FJY6) ([Q2FJY6_STAA3](http://www.uniprot.org/uniprot/Q2FJY6))        ESAT-6-like protein SAUSA300_0278                                                                        Secretion                                                                                22.33                         33.00                                            0.0044
  [Q2FDH3](https://www.ncbi.nlm.nih.gov/protein/Q2FDH3) ([DRP35_STAA3](http://www.uniprot.org/uniprot/Q2FDH3))         Lactonase Drp35                                                                                          Stress response, cell envelope stress                                                    735.67                        768.33                                           0.0044
  [Q2FEV0](https://www.ncbi.nlm.nih.gov/protein/Q2FEV0) ([ASP23_STAA3](http://www.uniprot.org/uniprot/Q2FEV0))         Alkaline shock protein 23 Asp23                                                                          Stress response, cell envelope stress/alkaline shock protein                             6.00                          25.67                                            1.3E−10
  [Q2FGH0](https://www.ncbi.nlm.nih.gov/protein/Q2FGH0) ([SODM1_STAA3](http://www.uniprot.org/uniprot/Q2FGH0))         Superoxide dismutase (Mn/Fe) 1 SodA                                                                      Stress response, oxidative stress                                                        2.00                          14.00                                            0.000000028
  [Q2FHD4](https://www.ncbi.nlm.nih.gov/protein/Q2FHD4) ([Q2FHD4_STAA3](http://www.uniprot.org/uniprot/Q2FHD4))        Glutathione peroxidase SAUSA300_1197                                                                     Stress response, oxidative stress                                                        17.67                         26.33                                            0.0089
  [Q2FIW1](https://www.ncbi.nlm.nih.gov/protein/Q2FIW1) ([Q2FIW1_STAA3](http://www.uniprot.org/uniprot/Q2FIW1))        Conserved hypothetical protein SAUSA300_0664                                                             Unknown                                                                                  72.33                         113.67                                           0.000000009
  [Q2FKC5](https://www.ncbi.nlm.nih.gov/protein/Q2FKC5) ([Q2FKC5_STAA3](http://www.uniprot.org/uniprot/Q2FKC5))        Cell wall surface anchor family protein SAUSA300_0136                                                    Unknown                                                                                  51.67                         77.33                                            0.000013
  [Q2FEJ7](https://www.ncbi.nlm.nih.gov/protein/Q2FEJ7) ([Q2FEJ7_STAA3](http://www.uniprot.org/uniprot/Q2FEJ7))        Conserved hypothetical protein SAUSA300_2246                                                             Unknown                                                                                  50.33                         75.00                                            0.000021
  [Q2FDZ7](https://www.ncbi.nlm.nih.gov/protein/Q2FDZ7) ([Q2FDZ7_STAA3](http://www.uniprot.org/uniprot/Q2FDZ7))        Conserved hypothetical protein SAUSA300_2447                                                             Unknown                                                                                  53.00                         73.67                                            0.00027
  [Q2FDH4](https://www.ncbi.nlm.nih.gov/protein/Q2FDH4) ([Y2620_STAA3](http://www.uniprot.org/uniprot/Q2FDH4))         UPF0312 protein SAUSA300_2620                                                                            Unknown                                                                                  7.67                          26.33                                            4.4E−09
  [Q2FHB6](https://www.ncbi.nlm.nih.gov/protein/Q2FHB6) ([Q2FHB6_STAA3](http://www.uniprot.org/uniprot/Q2FHB6))        Conserved hypothetical protein SAUSA300_1215                                                             Unknown                                                                                  4.00                          19.67                                            3.1E−09
  [Q2FIT2](https://www.ncbi.nlm.nih.gov/protein/Q2FIT2) ([Q2FIT2_STAA3](http://www.uniprot.org/uniprot/Q2FIT2))        Putative lipoprotein SAUSA300_0693                                                                       Unknown                                                                                  18.00                         33.00                                            0.000078
  [Q2FG19](https://www.ncbi.nlm.nih.gov/protein/Q2FG19) ([Q2FG19_STAA3](http://www.uniprot.org/uniprot/Q2FG19))        GAF domain-containing protein SAUSA300_1665                                                              Unknown                                                                                  10.00                         19.33                                            0.0011
  [Q2FKE8](https://www.ncbi.nlm.nih.gov/protein/Q2FKE8) ([Q2FKE8_STAA3](http://www.uniprot.org/uniprot/Q2FKE8))        IgG-binding protein SpA                                                                                  Virulence factor, immunomodulator                                                        470.00                        563.67                                           5.9E−10
  [Q2FHR3](https://www.ncbi.nlm.nih.gov/protein/Q2FHR3) ([Q2FHR3_STAA3](http://www.uniprot.org/uniprot/Q2FHR3))        Antibacterial protein PSM-β2                                                                             Virulence factor, immunomodulator                                                        31.00                         42.33                                            0.0067
  [Q2FES8](https://www.ncbi.nlm.nih.gov/protein/Q2FES8) ([Q2FES8_STAA3](http://www.uniprot.org/uniprot/Q2FES8))        MHC[^d^](#ngtab1.4){ref-type="table-fn"} class II analog protein Map-w SAUSA300_2164                     Virulence factor, immunomodulator                                                        11.67                         19.67                                            0.0056

Fisher's exact test.

PTS, phosphotransferase system.

FMN, flavin mononucleotide.

MHC, major histocompatibility complex.

###### 

Proteins decreased on *spl* mutant surface

  GenBank (UniProt) accession no.                                                                                 Name                                                                              Biological function(s)                                                                Avg no. of assigned spectra   *P* value[^a^](#ngtab2.1){ref-type="table-fn"}   
  --------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------- ------------------------------------------------------------------------------------- ----------------------------- ------------------------------------------------ -------------
  [Q2FJ78](https://www.ncbi.nlm.nih.gov/protein/Q2FJ78) ([SDRD_STAA3](http://www.uniprot.org/uniprot/Q2FJ78))     Serine-aspartate repeat-containing protein D SdrD                                 Adhesion, biofilm formation                                                           2.33                          0.00                                             0.0087
  [Q2FJ77](https://www.ncbi.nlm.nih.gov/protein/Q2FJ77) ([SDRE_STAA3](http://www.uniprot.org/uniprot/Q2FJ77))     Serine-aspartate repeat-containing protein E SdrE                                 Adhesion, biofilm formation                                                           34.33                         22.67                                            0.0082
  [Q2FJ79](https://www.ncbi.nlm.nih.gov/protein/Q2FJ79) ([SDRC_STAA3](http://www.uniprot.org/uniprot/Q2FJ79))     Serine-aspartate repeat-containing protein C SdrC                                 Adhesion, biofilm formation                                                           317.67                        32.67                                            0
  [Q2FHT6](https://www.ncbi.nlm.nih.gov/protein/Q2FHT6) ([THIO_STAA3](http://www.uniprot.org/uniprot/Q2FHT6))     Thioredoxin TrxA                                                                  Housekeeping, cell redox homeostasis                                                  7.67                          0.67                                             0.000014
  [Q2FJA0](https://www.ncbi.nlm.nih.gov/protein/Q2FJA0) ([RL7_STAA3](http://www.uniprot.org/uniprot/Q2FJA0))      50S ribosomal protein L7/L12 RpiL                                                 Housekeeping, translation                                                             81.00                         45.67                                            0.00000015
  [Q2FKP7](https://www.ncbi.nlm.nih.gov/protein/Q2FKP7) ([SYS_STAA3](http://www.uniprot.org/uniprot/Q2FKP7))      Seryl-tRNA synthetase SerS                                                        Housekeeping, translation, aminoacyl tRNA biosynthesis                                38.00                         13.00                                            1.6E−09
  [Q2FH16](https://www.ncbi.nlm.nih.gov/protein/Q2FH16) ([Q2FH16_STAA3](http://www.uniprot.org/uniprot/Q2FH16))   Glucose-specific IIA component crr                                                Metabolism, carbohydrate metabolism, sugar PTS[^b^](#ngtab2.2){ref-type="table-fn"}   163.67                        108.33                                           0.000000038
  [Q2FJ55](https://www.ncbi.nlm.nih.gov/protein/Q2FJ55) ([Q2FJ55_STAA3](http://www.uniprot.org/uniprot/Q2FJ55))   Phosphate acetyltransferase Pta                                                   Metabolism, carbohydrate metabolism                                                   14.67                         6.67                                             0.0027
  [Q2FIU1](https://www.ncbi.nlm.nih.gov/protein/Q2FIU1) ([Q2FIU1_STAA3](http://www.uniprot.org/uniprot/Q2FIU1))   Fructose 1-phosphate kinase FruB                                                  Metabolism, carbohydrate metabolism                                                   30.67                         8.33                                             4.7E−10
  [Q2FIB3](https://www.ncbi.nlm.nih.gov/protein/Q2FIB3) ([G6PI_STAA3](http://www.uniprot.org/uniprot/Q2FIB3))     Glucose-6-phosphate isomerase Pgi                                                 Metabolism, carbohydrate metabolism                                                   149.33                        114.67                                           0.00061
  [Q2FEL8](https://www.ncbi.nlm.nih.gov/protein/Q2FEL8) ([MOAC_STAA3](http://www.uniprot.org/uniprot/Q2FEL8))     Molybdenum cofactor biosynthesis protein MoaC                                     Metabolism, cofactors and vitamins                                                    2.33                          0.00                                             0.0087
  [Q2FJD1](https://www.ncbi.nlm.nih.gov/protein/Q2FJD1) ([Q2FJD1_STAA3](http://www.uniprot.org/uniprot/Q2FJD1))   Hypoxanthine phosphoribosyltransferase Hpt                                        Metabolism, purine metabolism                                                         538.00                        36.00                                            0
  [Q2FHN7](https://www.ncbi.nlm.nih.gov/protein/Q2FHN7) ([Q2FHN7_STAA3](http://www.uniprot.org/uniprot/Q2FHN7))   Dihydroorotase PyrC                                                               Metabolism, pyrimidine metabolism                                                     16.67                         1.33                                             3.9E−11
  [Q2FHR1](https://www.ncbi.nlm.nih.gov/protein/Q2FHR1) ([Q2FHR1_STAA3](http://www.uniprot.org/uniprot/Q2FHR1))   Uncharacterized N-acetyltransferase                                               Putative acetyltransferase                                                            6.33                          0.00                                             0
  [Q2FIC1](https://www.ncbi.nlm.nih.gov/protein/Q2FIC1) ([PPI1_STAA3](http://www.uniprot.org/uniprot/Q2FIC1))     Putative peptidyl-prolyl *cis*-*trans* isomerase SAUSA300_0857                    Putative housekeeping, protein folding                                                98.00                         40.67                                            1.1E−16
  [Q2FG31](https://www.ncbi.nlm.nih.gov/protein/Q2FG31) ([Y1653_STAA3](http://www.uniprot.org/uniprot/Q2FG31))    UPF0173 metal-dependent hydrolase SAUSA300_1653                                   Putative hydrolase activity                                                           183.67                        126.00                                           0.000000094
  [Q2FEC8](https://www.ncbi.nlm.nih.gov/protein/Q2FEC8) ([Y2315_STAA3](http://www.uniprot.org/uniprot/Q2FEC8))    Conserved hypothetical protein SAUSA300_2315                                      Putative lipoprotein                                                                  16.67                         5.67                                             0.000057
  [Q2FH36](https://www.ncbi.nlm.nih.gov/protein/Q2FH36) ([CSPA_STAA3](http://www.uniprot.org/uniprot/Q2FH36))     Cold shock protein CspA                                                           Regulation, transcription factor                                                      12.33                         5.00                                             0.0023
  [Q2FFR1](https://www.ncbi.nlm.nih.gov/protein/Q2FFR1) ([TRAP_STAA3](http://www.uniprot.org/uniprot/Q2FFR1))     Signal transduction protein TRAP                                                  Stress response, oxidative stress                                                     143.33                        100.67                                           0.0000086
  [Q2FEZ0](https://www.ncbi.nlm.nih.gov/protein/Q2FEZ0) ([Q2FEZ0_STAA3](http://www.uniprot.org/uniprot/Q2FEZ0))   General stress protein 20U Dps                                                    Stress response, starvation-inducible                                                 74.67                         53.00                                            0.0015
  [Q2FDL5](https://www.ncbi.nlm.nih.gov/protein/Q2FDL5) ([Q2FDL5_STAA3](http://www.uniprot.org/uniprot/Q2FDL5))   *N*-Acetylmuramoyl-[l]{.smallcaps}-alanine amidase domain protein SAUSA300_2579   Unknown                                                                               81.67                         47.33                                            0.00000044

Fisher's exact test.

PTS, phosphotransferase system.

Proteins with decreased levels on the surface included the cell wall-anchored adhesins SdrC, SdrD, and SdrE. These proteins are members of the Clf-Sdr MSCRAMM family, and all have been demonstrated to promote *S. aureus* adhesion or immune evasion ([@B46][@B47][@B48]). SdrC self-associates to promote biofilm formation ([@B49]), while both SdrC and SdrD promote *S. aureus* adherence to desquamated nasal epithelial cells ([@B38]). SdrE inhibits classical ([@B50]) and alternative ([@B51]) complement activation. The decrease of these proteins in the *spl* mutant suggests that one or more Spl proteases indirectly affect their abundance, rather than directly degrading them.

Secreted proteomics identified 48 proteins increased ([Table 3](#tab3){ref-type="table"}) and 28 proteins decreased ([Table 4](#tab4){ref-type="table"}) in the *spl* mutant relative to the USA300 WT strain. As in the surface proteomics, IsdA was increased in the Δ*spl*::*erm* mutant secretome, suggesting that it is more abundant both on the cell surface and in shedding from the cell due to cleavage or cell lysis. Multiple virulence factors were also increased, including LukD, Sbi, Nuc, and Efb. LukD is part of the LukED bicomponent pore-forming toxin, which is cytolytic to several cell types, including monocytes and polymorphonuclear leukocytes ([@B52], [@B53]). LukED has also been reported to promote *S. aureus* growth in human blood by facilitating iron scavenging ([@B54]). Like SpA, Sbi binds IgG, which prevents opsonophagocytosis of *S. aureus* ([@B55]). Nuc is a potent secreted DNase that is able to degrade neutrophil extracellular traps (NETs), promoting *S. aureus* survival in the lung and host killing in a murine model of respiratory infection ([@B56]). NET degradation by Nuc also induces macrophage death ([@B57]). Efb is a secreted protein that binds fibrinogen and complement C3 to form a protective shield around *S. aureus* and inhibit its phagocytic clearance ([@B58], [@B59]). The increased production of these proteins in the Δ*spl*::*erm* mutant suggests that it may have enhanced immunomodulatory properties that contribute to its increased lethality in the rabbit model of pneumonia.

###### 

Proteins increased in *spl* mutant spent medium

  GenBank (UniProt) accession no.                                                                                 Name                                                                          Biological function(s)                                                                Avg no. of assigned spectra   *P* value[^a^](#ngtab3.1){ref-type="table-fn"}   
  --------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------- ------------------------------------------------------------------------------------- ----------------------------- ------------------------------------------------ -------------
  [Q2FJV7](https://www.ncbi.nlm.nih.gov/protein/Q2FJV7) ([Q2FJV7_STAA3](http://www.uniprot.org/uniprot/Q2FJV7))   5′-Nucleotidase, lipoprotein e(P4) family SAUSA300_0307                       Acid phosphatase                                                                      80.00                         128.67                                           2.7E−09
  [Q2FHV1](https://www.ncbi.nlm.nih.gov/protein/Q2FHV1) ([ISDA_STAA3](http://www.uniprot.org/uniprot/Q2FHV1))     Iron-regulated surface determinant protein A IsdA                             Adhesion, immune evasion                                                              7.67                          23.67                                            0.00000036
  [Q2FF95](https://www.ncbi.nlm.nih.gov/protein/Q2FF95) ([CH60_STAA3](http://www.uniprot.org/uniprot/Q2FF95))     60-kDa chaperonin GroL                                                        Housekeeping, protein folding                                                         12.67                         32.67                                            0.00000014
  [Q2FF94](https://www.ncbi.nlm.nih.gov/protein/Q2FF94) ([CH10_STAA3](http://www.uniprot.org/uniprot/Q2FF94))     10-kDa chaperonin GroS                                                        Housekeeping, protein folding                                                         0.00                          2.33                                             0.0078
  [Q2FIM5](https://www.ncbi.nlm.nih.gov/protein/Q2FIM5) ([CLPP_STAA3](http://www.uniprot.org/uniprot/Q2FIM5))     ATP-dependent Clp protease proteolytic subunit ClpP                           Housekeeping, protein turnover                                                        5.33                          11.67                                            0.0055
  [Q2FJ98](https://www.ncbi.nlm.nih.gov/protein/Q2FJ98) ([RPOB_STAA3](http://www.uniprot.org/uniprot/Q2FJ98))     DNA-directed RNA polymerase subunit beta RpoB                                 Housekeeping, transcription                                                           0.00                          2.67                                             0.0039
  [Q2FHI1](https://www.ncbi.nlm.nih.gov/protein/Q2FHI1) ([EFTS_STAA3](http://www.uniprot.org/uniprot/Q2FHI1))     Elongation factor Ts/Tsf                                                      Housekeeping, translation                                                             80.33                         122.00                                           0.00000021
  [Q2FES2](https://www.ncbi.nlm.nih.gov/protein/Q2FES2) ([RS9_STAA3](http://www.uniprot.org/uniprot/Q2FES2))      30S ribosomal protein S9 RpsI                                                 Housekeeping, translation                                                             3.00                          19.00                                            5.9E−10
  [Q2FG80](https://www.ncbi.nlm.nih.gov/protein/Q2FG80) ([RL21_STAA3](http://www.uniprot.org/uniprot/Q2FG80))     50S ribosomal protein L21 RplU                                                Housekeeping, translation                                                             5.67                          14.67                                            0.00037
  [Q2FFJ4](https://www.ncbi.nlm.nih.gov/protein/Q2FFJ4) ([GATC_STAA3](http://www.uniprot.org/uniprot/Q2FFJ4))     Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit C GATC               Housekeeping, translation                                                             0.00                          2.67                                             0.0039
  [Q2FEX8](https://www.ncbi.nlm.nih.gov/protein/Q2FEX8) ([Q2FEX8_STAA3](http://www.uniprot.org/uniprot/Q2FEX8))   Glucosamine-fructose-6-phosphate aminotransferase (isomerizing) GlmS          Metabolism, amino acid metabolism                                                     0.00                          5.67                                             0.0000077
  [Q2FJ90](https://www.ncbi.nlm.nih.gov/protein/Q2FJ90) ([Q2FJ90_STAA3](http://www.uniprot.org/uniprot/Q2FJ90))   Putative pyridoxal phosphate-dependent acyltransferase SAUSA300_0535          Metabolism, amino acid metabolism                                                     0.00                          2.33                                             0.0078
  [Q2FDQ7](https://www.ncbi.nlm.nih.gov/protein/Q2FDQ7) ([LDH2_STAA3](http://www.uniprot.org/uniprot/Q2FDQ7))     [l]{.smallcaps}-Lactate dehydrogenase 2 Ldh2                                  Metabolism, carbohydrate metabolism, glycolysis                                       25.00                         55.00                                            0.000000003
  [Q2FHY7](https://www.ncbi.nlm.nih.gov/protein/Q2FHY7) ([Q2FHY7_STAA3](http://www.uniprot.org/uniprot/Q2FHY7))   Pyruvate dehydrogenase E1 component, alpha subunit PdhA                       Metabolism, carbohydrate metabolism                                                   12.33                         26.67                                            0.000044
  [Q2FHY5](https://www.ncbi.nlm.nih.gov/protein/Q2FHY5) ([Q2FHY5_STAA3](http://www.uniprot.org/uniprot/Q2FHY5))   Dihydrolipoamide acetyltransferase SAUSA300_0995                              Metabolism, carbohydrate metabolism                                                   5.33                          14.33                                            0.00029
  [Q2FKD2](https://www.ncbi.nlm.nih.gov/protein/Q2FKD2) ([Q2FKD2_STAA3](http://www.uniprot.org/uniprot/Q2FKD2))   Acetoin (diacetyl) reductase SAUSA300_0129                                    Metabolism, carbohydrate metabolism                                                   0.00                          2.33                                             0.0078
  [Q2FIB3](https://www.ncbi.nlm.nih.gov/protein/Q2FIB3) ([G6PI_STAA3](http://www.uniprot.org/uniprot/Q2FIB3))     Glucose-6-phosphate isomerase Pgi                                             Metabolism, carbohydrate metabolism, glycolysis, gluconeogenesis                      45.33                         71.67                                            0.000014
  [Q2FIL9](https://www.ncbi.nlm.nih.gov/protein/Q2FIL9) ([TPIS_STAA3](http://www.uniprot.org/uniprot/Q2FIL9))     Triosephosphate isomerase TpiA                                                Metabolism, carbohydrate metabolism, glycolysis, gluconeogenesis                      27.00                         52.00                                            0.00000063
  [Q2FE81](https://www.ncbi.nlm.nih.gov/protein/Q2FE81) ([GPMA_STAA3](http://www.uniprot.org/uniprot/Q2FE81))     2,3-Bisphosphoglycerate-dependent phosphoglycerate mutase GmpA                Metabolism, carbohydrate metabolism, glycolysis, gluconeogenesis                      13.33                         33.67                                            0.00000014
  [Q2FGM3](https://www.ncbi.nlm.nih.gov/protein/Q2FGM3) ([Q2FGM3_STAA3](http://www.uniprot.org/uniprot/Q2FGM3))   6-Phosphogluconate dehydrogenase, decarboxylating Gnd                         Metabolism, carbohydrate metabolism, pentose phosphate pathway                        29.33                         44.33                                            0.0015
  [Q2FHZ7](https://www.ncbi.nlm.nih.gov/protein/Q2FHZ7) ([Q2FHZ7_STAA3](http://www.uniprot.org/uniprot/Q2FHZ7))   Phosphocarrier protein HPr/PtsH                                               Metabolism, carbohydrate metabolism, sugar PTS[^b^](#ngtab3.2){ref-type="table-fn"}   41.00                         105.50                                           1.4E−14
  [Q2FIQ8](https://www.ncbi.nlm.nih.gov/protein/Q2FIQ8) ([Q2FIQ8_STAA3](http://www.uniprot.org/uniprot/Q2FIQ8))   Ribonucleoside-diphosphate reductase, beta subunit SAUSA300_0717              Metabolism, nucleotide metabolism                                                     3.33                          8.67                                             0.0057
  [Q2FI15](https://www.ncbi.nlm.nih.gov/protein/Q2FI15) ([FOLD_STAA3](http://www.uniprot.org/uniprot/Q2FI15))     Bifunctional protein FolD                                                     Metabolism, one-carbon metabolism, tetrahydrofolate interconversion                   2.67                          7.33                                             0.0081
  [Q2FJ56](https://www.ncbi.nlm.nih.gov/protein/Q2FJ56) ([Y569_STAA3](http://www.uniprot.org/uniprot/Q2FJ56))     UPF0447 protein SAUSA300_0569                                                 Putative heme-dependent oxidoreductase                                                0.00                          9.00                                             7.5E−09
  [Q2FJP2](https://www.ncbi.nlm.nih.gov/protein/Q2FJP2) ([Q2FJP2_STAA3](http://www.uniprot.org/uniprot/Q2FJP2))   Conserved hypothetical protein SAUSA300_0372                                  Putative lipoprotein                                                                  92.33                         122.33                                           0.00022
  [Q2FKJ0](https://www.ncbi.nlm.nih.gov/protein/Q2FKJ0) ([Q2FKJ0_STAA3](http://www.uniprot.org/uniprot/Q2FKJ0))   Putative lysophospholipase SAUSA300_0070                                      Putative lysophospholipase                                                            0.00                          5.00                                             0.000031
  [Q2FE21](https://www.ncbi.nlm.nih.gov/protein/Q2FE21) ([Y2422_STAA3](http://www.uniprot.org/uniprot/Q2FE21))    Uncharacterized oxidoreductase SAUSA300_2422                                  Putative oxidoreductase                                                               0.67                          4.00                                             0.0065
  [Q2FEG8](https://www.ncbi.nlm.nih.gov/protein/Q2FEG8) ([Q2FEG8_STAA3](http://www.uniprot.org/uniprot/Q2FEG8))   Oxidoreductase, short-chain dehydrogenase/reductase family GN=SAUSA300_2275   Putative oxidoreductase                                                               0.00                          3.00                                             0.002
  [Q2FFM0](https://www.ncbi.nlm.nih.gov/protein/Q2FFM0) ([Q2FFM0_STAA3](http://www.uniprot.org/uniprot/Q2FFM0))   Uncharacterized putative glycosyl hydrolase SAUSA300_1856                     Putative peptidase activity (endopeptidase)                                           11.33                         22.67                                            0.0005
  [Q2FG28](https://www.ncbi.nlm.nih.gov/protein/Q2FG28) ([Y1656_STAA3](http://www.uniprot.org/uniprot/Q2FG28))    Putative universal stress protein SAUSA300_1656                               Putative stress response protein                                                      3.33                          12.33                                            0.00005
  [Q2FH36](https://www.ncbi.nlm.nih.gov/protein/Q2FH36) ([CSPA_STAA3](http://www.uniprot.org/uniprot/Q2FH36))     Cold shock protein CspA                                                       Regulation, transcription factor                                                      5.33                          27.33                                            3.7E−12
  [Q2FJY5](https://www.ncbi.nlm.nih.gov/protein/Q2FJY5) ([Q2FJY5_STAA3](http://www.uniprot.org/uniprot/Q2FJY5))   Type VII secretion system protein EsaA SAUSA300_0279                          Secretion                                                                             0.00                          2.33                                             0.0078
  [Q2FEV0](https://www.ncbi.nlm.nih.gov/protein/Q2FEV0) ([ASP23_STAA3](http://www.uniprot.org/uniprot/Q2FEV0))    Alkaline shock protein 23 Asp23                                               Stress response, cell envelope stress/alkaline shock protein                          120.00                        173.67                                           0.000000029
  [Q2FGH0](https://www.ncbi.nlm.nih.gov/protein/Q2FGH0) ([SODM1_STAA3](http://www.uniprot.org/uniprot/Q2FGH0))    Superoxide dismutase \[Mn/Fe\] 1 SodA                                         Stress response, oxidative stress                                                     17.33                         35.00                                            0.000014
  [Q2FDV8](https://www.ncbi.nlm.nih.gov/protein/Q2FDV8) ([CLPL_STAA3](http://www.uniprot.org/uniprot/Q2FDV8))     ATP-dependent Clp protease ClpL                                               Stress response, thermotolerance                                                      19.33                         42.33                                            0.00000021
  [Q2FJK5](https://www.ncbi.nlm.nih.gov/protein/Q2FJK5) ([Q2FJK5_STAA3](http://www.uniprot.org/uniprot/Q2FJK5))   Conserved hypothetical protein SAUSA300_0409                                  Unknown                                                                               2.33                          12.00                                            0.0000045
  [Q2FGB1](https://www.ncbi.nlm.nih.gov/protein/Q2FGB1) ([Y1572_STAA3](http://www.uniprot.org/uniprot/Q2FGB1))    Conserved hypothetical protein UPF0473 protein SAUSA300_1572                  Unknown                                                                               0.00                          6.00                                             0.0000038
  [Q2FJN1](https://www.ncbi.nlm.nih.gov/protein/Q2FJN1) ([Q2FJN1_STAA3](http://www.uniprot.org/uniprot/Q2FJN1))   Conserved hypothetical protein SAUSA300_0383                                  Unknown                                                                               0.00                          4.00                                             0.00025
  [Q2FFJ2](https://www.ncbi.nlm.nih.gov/protein/Q2FFJ2) ([Q2FFJ2_STAA3](http://www.uniprot.org/uniprot/Q2FFJ2))   CamS sex pheromone cAM373 SAUSA300_1884                                       Unknown                                                                               1.67                          5.67                                             0.0085
  [Q2FKC5](https://www.ncbi.nlm.nih.gov/protein/Q2FKC5) ([Q2FKC5_STAA3](http://www.uniprot.org/uniprot/Q2FKC5))   Cell wall surface anchor family protein SAUSA300_0136                         Unknown                                                                               0.00                          3.33                                             0.00098
  [Q2FG32](https://www.ncbi.nlm.nih.gov/protein/Q2FG32) ([Q2FG32_STAA3](http://www.uniprot.org/uniprot/Q2FG32))   Universal stress protein family protein SAUSA300_1652                         Unknown                                                                               0.00                          3.33                                             0.00098
  [Q2FEV8](https://www.ncbi.nlm.nih.gov/protein/Q2FEV8) ([Q2FEV8_STAA3](http://www.uniprot.org/uniprot/Q2FEV8))   Transporter gate domain protein SAUSA300_2133                                 Unknown                                                                               0.00                          2.67                                             0.0039
  [Q2FIK2](https://www.ncbi.nlm.nih.gov/protein/Q2FIK2) ([Q2FIK2_STAA3](http://www.uniprot.org/uniprot/Q2FIK2))   Thermonuclease Nuc                                                            Virulence factor                                                                      323.00                        369.67                                           0.0011
  [Q2FIH7](https://www.ncbi.nlm.nih.gov/protein/Q2FIH7) ([Q2FIH7_STAA3](http://www.uniprot.org/uniprot/Q2FIH7))   Staphylococcal enterotoxin Q Seq/SelQ                                         Virulence factor                                                                      21.00                         56.00                                            1.6E−12
  [Q2FFA2](https://www.ncbi.nlm.nih.gov/protein/Q2FFA2) ([LUKL2_STAA3](http://www.uniprot.org/uniprot/Q2FFA2))    Uncharacterized leukocidin-like protein 2 SAUSA300_1975                       Virulence factor, cytolysin                                                           202.33                        230.33                                           0.01
  [Q2FFR9](https://www.ncbi.nlm.nih.gov/protein/Q2FFR9) ([Q2FFR9_STAA3](http://www.uniprot.org/uniprot/Q2FFR9))   Leukotoxin LukD                                                               Virulence factor, cytolysin                                                           2.00                          2.33                                             0.00000021
  [Q2FE79](https://www.ncbi.nlm.nih.gov/protein/Q2FE79) ([SBI_STAA3](http://www.uniprot.org/uniprot/Q2FE79))      Immunoglobulin-binding protein Sbi                                            Virulence factor, immunomodulator                                                     54.67                         90.00                                            0.0000002
  [Q2FHS5](https://www.ncbi.nlm.nih.gov/protein/Q2FHS5) ([Q2FHS5_STAA3](http://www.uniprot.org/uniprot/Q2FHS5))   Fibrinogen-binding protein Efb                                                Virulence factor, immunomodulator                                                     0.00                          5.00                                             0.000031

Fisher's exact test.

PTS, phosphotransferase system.

###### 

Proteins decreased in *spl* mutant spent medium

  GenBank (UniProt) accession no.                                                                                 Name                                                                                   Biological function                                       Avg no. of assigned spectra   *P* value[^a^](#ngtab4.1){ref-type="table-fn"}   
  --------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------- --------------------------------------------------------- ----------------------------- ------------------------------------------------ -------------
  [Q2FE04](https://www.ncbi.nlm.nih.gov/protein/Q2FE04) ([Q2FE04_STAA3](http://www.uniprot.org/uniprot/Q2FE04))   Fibronectin-binding protein B FnBPB                                                    Adhesion                                                  5.67                          1.00                                             0.0013
  [Q2FE08](https://www.ncbi.nlm.nih.gov/protein/Q2FE08) ([Q2FE08_STAA3](http://www.uniprot.org/uniprot/Q2FE08))   Putative cell wall surface anchor family protein surface protein G SAUSA300_2436       Adhesion, biofilm formation (nonfunctional in SAUSA300)   193.33                        126.67                                           4E−11
  [Q2FI25](https://www.ncbi.nlm.nih.gov/protein/Q2FI25) ([Q2FI25_STAA3](http://www.uniprot.org/uniprot/Q2FI25))   Autolysin Atl                                                                          Autolysis                                                 657.67                        605.33                                           0.0043
  [Q2FJH7](https://www.ncbi.nlm.nih.gov/protein/Q2FJH7) ([SLE1_STAA3](http://www.uniprot.org/uniprot/Q2FJH7))     *N*-Acetylmuramoyl-[l]{.smallcaps}-alanine amidase Sle1                                Cell wall turnover                                        72.67                         54.33                                            0.0027
  [Q2FDT8](https://www.ncbi.nlm.nih.gov/protein/Q2FDT8) ([ISAA_STAA3](http://www.uniprot.org/uniprot/Q2FDT8))     Transglycosylase IsaA                                                                  Cell wall turnover                                        140.00                        99.33                                            0.0000026
  [Q2FEP2](https://www.ncbi.nlm.nih.gov/protein/Q2FEP2) ([RL2_STAA3](http://www.uniprot.org/uniprot/Q2FEP2))      50S ribosomal protein L2 RplB                                                          Housekeeping, translation                                 6.00                          0.67                                             0.0002
  [Q2FJP8](https://www.ncbi.nlm.nih.gov/protein/Q2FJP8) ([RS6_STAA3](http://www.uniprot.org/uniprot/Q2FJP8))      30S ribosomal protein s6 RpsF                                                          Housekeeping, translation                                 11.67                         1.00                                             0.000000033
  [Q2FE84](https://www.ncbi.nlm.nih.gov/protein/Q2FE84) ([Q2FE84_STAA3](http://www.uniprot.org/uniprot/Q2FE84))   Amino acid ABC transporter, amino acid-binding protein SAUSA300_2359                   Membrane transporter                                      33.33                         22.00                                            0.005
  [Q2FIL7](https://www.ncbi.nlm.nih.gov/protein/Q2FIL7) ([ENO_STAA3](http://www.uniprot.org/uniprot/Q2FIL7))      Enolase Eno                                                                            Metabolism, carbohydrate metabolism, glycolysis           354.67                        297.00                                           0.000037
  [Q2FJM5](https://www.ncbi.nlm.nih.gov/protein/Q2FJM5) ([GUAA_STAA3](http://www.uniprot.org/uniprot/Q2FJM5))     GMP synthase (glutamine-hydrolyzing) GuaA                                              Metabolism, nucleotide metabolism, purine metabolism      18.00                         9.67                                             0.004
  [Q2FFI6](https://www.ncbi.nlm.nih.gov/protein/Q2FFI6) ([Q2FFI6_STAA3](http://www.uniprot.org/uniprot/Q2FFI6))   Staphopain A ScpA                                                                      Protease, cysteine protease                               102.33                        69.00                                            0.0000053
  [Q2FFT4](https://www.ncbi.nlm.nih.gov/protein/Q2FFT4) ([SPLF_STAA3](http://www.uniprot.org/uniprot/Q2FFT4))     Serine protease SplF                                                                   Protease, serine protease                                 3.67                          0.00                                             0.00000024
  [Q2FFT0](https://www.ncbi.nlm.nih.gov/protein/Q2FFT0) ([SPLB_STAA3](http://www.uniprot.org/uniprot/Q2FFT0))     Serine protease SplB                                                                   Protease, serine protease                                 9.67                          0.00                                             3.3E−18
  [Q2FFT1](https://www.ncbi.nlm.nih.gov/protein/Q2FFT1) ([SPLC_STAA3](http://www.uniprot.org/uniprot/Q2FFT1))     Serine protease SplC                                                                   Protease, serine protease                                 15.00                         0.00                                             2.8E−14
  [Q2FFS8](https://www.ncbi.nlm.nih.gov/protein/Q2FFS8) ([Q2FFS8_STAA3](http://www.uniprot.org/uniprot/Q2FFS8))   Conserved hypothetical protein SAUSA300_1759                                           Putative β-lactamase                                      68.33                         53.33                                            0.01
  [Q2FJK6](https://www.ncbi.nlm.nih.gov/protein/Q2FJK6) ([Q2FJK6_STAA3](http://www.uniprot.org/uniprot/Q2FJK6))   Conserved hypothetical protein SAUSA300_0408                                           Putative surface protein                                  58.00                         43.33                                            0.0065
  [Q2FHI3](https://www.ncbi.nlm.nih.gov/protein/Q2FHI3) ([Cody_STAA3](http://www.uniprot.org/uniprot/Q2FHI3))     GTP-sensing transcriptional pleiotropic repressor CodY                                 Regulation, transcription factor                          5.67                          1.33                                             0.0036
  [Q2FI16](https://www.ncbi.nlm.nih.gov/protein/Q2FI16) ([Q2FI16_STAA3](http://www.uniprot.org/uniprot/Q2FI16))   Chitinase-related protein SAUSA300_0964                                                Unknown                                                   7.67                          2.33                                             0.0026
  [Q2FEJ0](https://www.ncbi.nlm.nih.gov/protein/Q2FEJ0) ([Q2FEJ0_STAA3](http://www.uniprot.org/uniprot/Q2FEJ0))   Secretory antigen precursor SsaA                                                       Unknown                                                   18.67                         8.33                                             0.00037
  [Q2FI95](https://www.ncbi.nlm.nih.gov/protein/Q2FI95) ([Q2FI95_STAA3](http://www.uniprot.org/uniprot/Q2FI95))   Putative surface protein similar to Map-w SAUSA300_0883                                Unknown                                                   279.00                        238.67                                           0.00098
  [Q2FE76](https://www.ncbi.nlm.nih.gov/protein/Q2FE76) ([Q2FE76_STAA3](http://www.uniprot.org/uniprot/Q2FE76))   Gamma-hemolysin component B HlgB                                                       Virulence factor, cytolysin                               190.67                        153.33                                           0.0002
  [Q2FFA3](https://www.ncbi.nlm.nih.gov/protein/Q2FFA3) ([LUKL1_STAA3](http://www.uniprot.org/uniprot/Q2FFA3))    Uncharacterized leukocidin-like protein 1 SAUSA300_1974                                Virulence factor, cytolysin                               153.00                        105.33                                           0.00000013
  [Q2FF89](https://www.ncbi.nlm.nih.gov/protein/Q2FF89) ([Q2FF89_STAA3](http://www.uniprot.org/uniprot/Q2FF89))   Delta-hemolysin Hld                                                                    Virulence factor, cytolysin, immunomodulator              15.33                         2.67                                             0.000000067
  [Q2FHR4](https://www.ncbi.nlm.nih.gov/protein/Q2FHR4) ([Q2FHR4_STAA3](http://www.uniprot.org/uniprot/Q2FHR4))   Antibacterial protein PSM-β1                                                           Virulence factor, immunomodulator                         459.33                        383.00                                           0.0000017
  [Q2FFF8](https://www.ncbi.nlm.nih.gov/protein/Q2FFF8) ([SCIN_STAA3](http://www.uniprot.org/uniprot/Q2FFF8))     SCIN                                                                                   Virulence factor, immunomodulator                         326.67                        250.33                                           0.000000013
  [Q2FES8](https://www.ncbi.nlm.nih.gov/protein/Q2FES8) ([Q2FES8_STAA3](http://www.uniprot.org/uniprot/Q2FES8))   MHC[^b^](#ngtab4.2){ref-type="table-fn"} class II analog protein Map-w SAUSA300_2164   Virulence factor, immunomodulator                         578.67                        500.67                                           0.000012
  [Q2FHR3](https://www.ncbi.nlm.nih.gov/protein/Q2FHR3) ([Q2FHR3_STAA3](http://www.uniprot.org/uniprot/Q2FHR3))   Antibacterial protein PSM-β2                                                           Virulence factor, immunomodulator                         210.00                        86.67                                            6E−37
  [Q2FIH8](https://www.ncbi.nlm.nih.gov/protein/Q2FIH8) ([Q2FIH8_STAA3](http://www.uniprot.org/uniprot/Q2FIH8))   Staphylococcal enterotoxin K Sek/SelK                                                  Virulence factor, toxin                                   32.00                         19.33                                            0.0013

Fisher's exact test.

MHC, major histocompatibility complex.

In contrast, multiple secreted virulence factors are decreased in abundance in the *spl* mutant, including the Υ hemolysin component HlgB, the staphylococcal complement inhibitor (SCIN), and the δ hemolysin Hld ([Table 4](#tab4){ref-type="table"}). HlgB is the F subunit of the Υ hemolysin pore-forming toxins ([@B60][@B61][@B62]). Hlg toxins have been shown to contribute to virulence in a murine model of septic arthritis ([@B63]) and to induce eye injury when directly injected intraocularly into rabbits ([@B64]), as well as promote *S. aureus* virulence in rabbit endophthalmitis infection models ([@B65][@B66][@B67]). SCIN is a secreted protein that inhibits complement activation by binding to C3 convertases ([@B68], [@B69]). The Hld cytolysin is translated from RNAIII, the regulatory RNA that is the effector of the staphylococcal *agr* system ([@B70]). Decreased RNAIII would indicate lower *agr* activation in the *spl* mutant; however, our finding that Hla and ScpA activities are not decreased in the *spl* mutant suggests that this is not the case ([Fig. 3B](#fig3){ref-type="fig"} and [C](#fig3){ref-type="fig"}). Altered Hld levels therefore may be due to a posttranslational modification.

DISCUSSION {#h2}
==========

The Spl proteases are an intriguing topic because, despite evidence that they contribute to *S. aureus*-host interaction, their specific functions have not been identified. Structural and activity analyses of SplA, SplB, and SplD have revealed that these enzymes are likely highly specific, given that they have cleavage preferences at subsites beyond the P1 residue of cleavage ([@B26], [@B71][@B72][@B73]). Further, the Spls are not produced as zymogens but, in some cases, appear to require the binding of a preferred substrate in order to take on an enzymatically active conformation ([@B72]), as has been demonstrated by characterization of SplB activity ([@B71]). The goals of this study were to investigate the function of the *spl* operon in virulence and to identify possible substrates of the Spl proteases.

The virulence phenotype of the *spl* mutant is complex, since the mutant-infected animals had a statistically insignificant change in lethality but more localized, less disseminated lung damage. We tested SplA cleavage of predicted substrate mucin 16 ([@B26]) and found that it induces the shedding of this protein from CalU-3 cells. SplA may therefore promote *S. aureus* invasion and spreading by removing mucin 16 from epithelial cells. Since mucin 16 is found on ocular, airway, and female reproductive tract epithelial cells ([@B19]), this function could facilitate infection at multiple body sites. This finding is also the first report of an Spl enzyme potentially cleaving a host target.

Proteomic studies of the secreted and surface proteins present on the USA300 WT and *spl* mutant strains revealed many proteins altered in abundance. The fact that intracellular and housekeeping genes were identified is one caveat of this experiment, suggesting that cell lysis may have occurred during sample preparation. However, none of the proteins identified contain the consensus motifs that have been identified for substrates of the Spls. These are W/Y-L-Y-S/T for SplA ([@B26]), W-E-L-Q for SplB ([@B71]), and R-Y/W-P/L-T/L/I/V-S for SplD ([@B73]). We therefore cannot predict any specific hits that are directly cleaved. However, it is possible that the Spls are able to cleave substrates with some deviation from these consensus motifs. The abundance of some proteins may also be indirectly affected by the Spls. Alternatively, SplC or SplE could be responsible for some effects, since only SplA, SplB, and SplD cleavage preferences have been published. Considering that the amino acid sequences of SplD and SplF are 94.6% identical ([@B3]), their activities are likely identical.

The proteomic results show virulence factors in both the increased and decreased protein groups, so it is difficult to predict specific virulence factors that are responsible for the virulence phenotype observed. A few of the proteomic hits also do not match our *in vitro* studies. For example, ScpA was found to be decreased in the *spl* mutant ([Table 4](#tab4){ref-type="table"}) but unaltered when we tested its activity with a specific ScpA substrate ([Fig. 3C](#fig3){ref-type="fig"}). The decrease in Hld also could correspond to lower RNAIII, indicating lower *agr* activation, but this was also not observed in our Hla and protease studies ([Fig. 3B](#fig3){ref-type="fig"} and [C](#fig3){ref-type="fig"}). Hld translation could therefore be altered, or it may be degraded posttranslationally. Hld is a member of the phenol-soluble modulin (PSM) family of peptides, which are known to be protease labile ([@B74], [@B75]). Thus, the lower Hld levels in the *spl* mutant could be due to degradation by an unknown protease.

Our findings have some similarities to a previous study that tested the virulence and proteomics of a total protease knockout of *S. aureus* ([@B74]). In a murine model of sepsis, the protease null mutant had increased lethality in mice but reduced invasion of organs. Proteomics also identified an increase in the abundance of *agr*-regulated virulence factors such as Hla and other leukocidins. Although we did not observe an increase in Hla, some of our proteomic results mirrored those of the previously reported study. For example, the previous paper reported increased abundance of Sbi, LukE, Seq, Geh, Efb, IsdA, IsaA, Spa, and EbpS in the protease null mutant, all of which were increased in our *spl* mutant as well ([Tables 2](#tab2){ref-type="table"} and [4](#tab4){ref-type="table"}). This suggests that the Spl proteases contributed to the previously reported phenotypes and corroborates the model in which secreted proteases modulate virulence factor production.

A recent study found that the Spls are important mediators of the host allergic airway response to *S. aureus* ([@B8]). In the serum of five healthy *S. aureus* carriers, strong IgG4 antibody binding to the Spls was observed. Purified SplD induced a Th2-type response in a tissue explant model with tissue from human nasal polyps. In a mouse allergy model, inhalation of SplD also induced eosinophil infiltration and IgE antibodies to SplD ([@B8]). IgG4, IgE, and other Th2-mediated responses are involved in allergic airway disease ([@B75]). Interestingly, many allergens that induce allergic responses in the lungs are proteases, including proteases produced by *Aspergillus fumigatus* ([@B76]) and mites and cockroaches ([@B77]). These findings indicate that, in addition to SplD, the other Spls may cleave substrates in airway cells and contribute to allergic airway disease and other immune responses in the airway. Our finding that SplA induces mucin 16 shedding adds to this model, as mucin 16 removal could facilitate the ability of the other proteases to act on host cell targets.

The Spls are clearly highly specific proteases, and their natural targets have been difficult to identify. However, mounting evidence suggests that they are expressed *in vivo* and affect host immune responses. Future work will tease apart the roles of individual Spls in interaction with the host and unravel their host effects, hopefully by identification of their cleavage substrates in the host.

MATERIALS AND METHODS {#h3}
=====================

Strains and plasmids. {#s3.1}
---------------------

LAC is a USA300 CA-MRSA strain ([@B78]), and the erythromycin-sensitive version called USA300 WT ([@B79]) was used in this study. The LAC Δ*spl*::*erm* mutant strain was generated by phage transduction from RN6390 Δ*spl*::*erm* ([@B3]) into LAC with φ80α. Strains were cultured on tryptic soy agar (TSA) plates or in tryptic soy broth (TSB) at 37°C, with shaking at 200 rpm for broth culture.

The SplA purification plasmid pSK236/*splA*6xHis was kindly provided by Suzan Rooijakkers of the University Medical Center Utrecht. This plasmid contains C-terminally His6-tagged *splA* that is under control of the *S. aureus* scn (SCIN) promoter. The plasmid was moved by electroporation into *S. aureus* Newman to maximize SplA production, since *scn* is positively regulated by the *sae* system ([@B80]) and *sae* expression is enhanced in the Newman strain ([@B81]).

Rabbit pneumonia model. {#s3.2}
-----------------------

The rabbit pneumonia model was prepared in accordance with reference [@B18]. The USA300 WT and Δ*spl*::*erm* mutant strains were grown overnight in TSB, washed once in sterile TSB, and resuspended at 1 × 10^10^ CFU/ml. Adult Dutch belted rabbits (Bakkom) were anesthetized with ketamine (25 mg/kg) and xylazine (20 mg/kg) administered subcutaneously. A ventral midline incision was made through the skin and into the trachea; a catheter was then inserted and fed into the lungs. Approximately 2 × 10^9^ CFU of washed bacteria in 200 µl of TSB was delivered through the catheter to each rabbit. Inocula were plated to confirm the dose given. The actual dose was 2 × 10^9^ to 3 × 10^9^ CFU. The incisions were closed, and the rabbits were monitored for 6 days. Over the course of the experiment, the rabbits were treated for pain with buprenorphine (0.05 mg/kg twice daily) through intramuscular injection. Rabbits were euthanized by intravenous injection of 1 ml of a mixture of the sodium salts of phenytoin and pentobarbital (Beuthanasia-D) either on day 6 or if they were found during the course of the experiment to be unable to right themselves or exhibit escape behavior. At the time of death, rabbit lungs were photographed; tissues were fixed (10% neutral buffered formalin), processed, and embedded; and tissue sections were stained with H&E and histopathologically scored in accordance with standard principles ([@B82]).

SplA purification. {#s3.3}
------------------

*S. aureus* Newman expressing pSK236/*splA*6xHis was grown overnight in 5 ml of TSB plus 10 µg/ml chloramphenicol, and then the entire culture was added to 200 ml of TSB and grown overnight. The spent medium was harvested by centrifugation and filtration, and 121 g of ammonium sulfate was slowly dissolved in the spent medium to achieve approximately 85% saturation. The sample was centrifuged at 30,000 × *g* at 4°C for 30 min to collect the pellet, which was dissolved in 10 ml of PBS and dialyzed into 50 mM Na~2~HPO~4~ with 0.3 M NaCl at pH 8.0 and then into the same buffer with 10 mM imidazole for loading onto the His-Select nickel affinity gel (Sigma). Batch purification with the His-Select nickel affinity gel was performed according to the manufacturer's protocol. The final protein was dialyzed into PBS and stored at −80°C.

Mucin 16 slot blot assay. {#s3.4}
-------------------------

CalU-3 cells were seeded at 500,000/well into 24-well plates and cultured with 1 ml/well minimum essential medium (Gibco) containing 10% heat-inactivated fetal bovine serum (Gibco) and 1× nonessential amino acids (Gibco) at 37°C in 5% CO~2~ for 2 days. For the SplA-induced shedding experiment, purified SplA was added to fresh medium without serum at 500 µl/well to avoid serum cross-reactivity with the mucin 16 antibody. For inhibition of SplA, 3,4-DCI was added at a final concentration of 10 µM. The cells were incubated with SplA at 37°C in 5% CO~2~ for 2 h, and the medium was removed for Western blotting. For the slot blot assay, samples were loaded onto polyvinylidene difluoride (PVDF) with a vacuum and a slot blot apparatus. The PVDF was first equilibrated in methanol for 15 s, in distilled H~2~O (dH~2~O) for 2 min, and in TBS plus 0.5% Tween 20 for 5 min. It was then placed into the slot blot apparatus on top of two pieces of filter paper wetted with TBS plus 0.5% Tween, and the vacuum was turned on low to drain excess buffer. A 100-µl volume of each sample was loaded into the slots, and then the vacuum was turned on until the liquid was absorbed. TBS plus 0.5% Tween 20 at 100 µl/well was then loaded to wash any unbound sample from the wells. The membrane was dipped into methanol and then dH~2~O and then blocked for 2 h in 5% BSA in TBS plus 0.5% Tween 20. A primary mouse anti-CA 125 antibody was diluted 1:200 in blocking buffer and incubated for 1 h, and a horseradish peroxidase-conjugated goat anti-mouse secondary antibody was diluted 1:5,000 in blocking buffer and incubated for 1 h. The membrane was washed with TBS plus 0.5% Tween 20 between steps. The membrane was incubated in chemiluminescent substrate and exposed to film.

Blood survival assay. {#s3.5}
---------------------

Blood survival of the USA300 WT and Δ*spl*::*erm* mutant strains was measured as previously described ([@B83]). Strains were subcultured and grown to mid-log phase (optical density at 600 nm \[OD~600~\] of 0.8) and centrifuged at 8,000 × *g* for 5 min. Bacteria were washed twice in TSB and resuspended to 1 ml. A 100-µl volume was added to 1 ml of heparinized human blood, and the culture was placed on a tumbler at 37°C for 3 h. Serial dilutions were plated on TSA and counted.

Hemolysis activity assay. {#s3.6}
-------------------------

An Hla activity assay was performed as previously described ([@B84]). Briefly, overnight cultures of the USA300 WT and Δ*spl*::*erm* mutant strains were subcultured at 1:500 in TSB and grown for 24 h. Spent medium from these cultures was serially diluted 2-fold across a 96-well plate. Defibrinated rabbit blood (HemoStat Laboratories) was centrifuged to pellet rabbit erythrocytes, which were washed three times in 1.1× PBS and resuspended to a final concentration of 3%. A 30-µl volume of each spent medium dilution was mixed with 70 µl of the erythrocyte solution in the 96-well plate and then incubated statically at room temperature for 1 h, after which the OD~630~ was measured. The OD~630~ was plotted versus the percent spent medium on a four-parameter logistic curve with the Prism program, and the midpoint of the curve (the percentage of medium needed to lyse 50% of the erythrocytes) was used as an indicator of activity.

ScpA activity assay. {#s3.7}
--------------------

Overnight cultures of the USA300 WT and Δ*spl*::*erm* mutant strains were diluted to an OD~600~ of 0.1 in 25 ml of TSB and grown for 24 h. At selected time points, spent medium was collected and incubated with a fluorescent resonance energy transfer (FRET) substrate that is based on the CXCR2 ScpA cleavage site ([@B34]). The FRET assay was performed in accordance with reference [@B85]. The substrate was resuspended to a concentration of 50 µM in 20 mM Tris-HCl, pH 7.4. Spent medium was also buffered to 20 mM Tris-HCl, pH 7.4. The substrate (25 µl) was mixed with 175 µl of buffered spent medium, and fluorescence (excitation, 490 nm; emission, 520 nm) measurements were taken every 2 min for 30 min with a Tecan plate reader. The activity at each time point was expressed as the slope (fluorescence/time).

Aur and hemolysis plate activity assays. {#s3.8}
----------------------------------------

Overnight cultures of the USA300 WT and Δ*spl*::*erm* mutant strains were spotted in 5-µl amounts onto blood agar (5% \[vol/vol\] rabbit blood and 3% Bacto agar) or milk agar (5% nonfat dry milk and 3% Bacto agar) plates. The plates were incubated overnight at 37°C, and pictures of colonies with zones of clearing were taken.

Proteomics. {#s3.9}
-----------

Overnight cultures of the USA300 WT and Δ*spl*::*erm* mutant strains were grown in TSB and harvested for secreted and surface proteomic profiling. Secreted proteome profiling was carried out in accordance with reference [@B86], and surface proteomic analysis was carried out in accordance with reference [@B87].
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